Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rudin

Showing results (521-530 of 524) with videos related to

Pageof 53
Sort By:
You have reached the last page of results.This site can display upto 524 results.
Cancer Cell|March 27, 2026
Cancer type-specific variation in patterns of driver alterations across 50,000 tumorsChaitanya Bandlamudi, Daniel Muldoon, Ino de Bruijn, et al.
Nature Communications|May 13, 2020
Protein-altering germline mutations implicate novel genes related to lung cancer developmentXuemei Ji, Semanti Mukherjee, Maria Teresa Landi, et al.
Cell|August 16, 2020
Extracellular Vesicle and Particle Biomarkers Define Multiple Human CancersAyuko Hoshino, Han Sang Kim, Linda Bojmar, et al.
Nature|October 9, 2024
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitorsFerdinandos Skoulidis, Haniel A Araujo, Minh Truong Do, et al.
Pageof 53

Showing results (521-530 of 524) with videos related to

Sort By:
Pageof 53
You have reached the last page of results.This site can display upto 524 results.
Cancer Cell|March 27, 2026
Cancer type-specific variation in patterns of driver alterations across 50,000 tumorsChaitanya Bandlamudi, Daniel Muldoon, Ino de Bruijn, et al.
Nature Communications|May 13, 2020
Protein-altering germline mutations implicate novel genes related to lung cancer developmentXuemei Ji, Semanti Mukherjee, Maria Teresa Landi, et al.
Cell|August 16, 2020
Extracellular Vesicle and Particle Biomarkers Define Multiple Human CancersAyuko Hoshino, Han Sang Kim, Linda Bojmar, et al.
Nature|October 9, 2024
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitorsFerdinandos Skoulidis, Haniel A Araujo, Minh Truong Do, et al.
Pageof 53